DUBLIN, Calif.--(BUSINESS WIRE)--SuperGen Inc. (Nasdaq:SUPG - News), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that it will release its 2009 third quarter financial results on Monday, October 26, 2009. SuperGen’s management team will provide details of the Company’s financial results and any revised outlook for the future.
A press release will be issued following the close of the market on October 26th. The Company will host a webcast conference call to discuss the results at 4:30 p.m. ET / 1:30 p.m. PT. The webcast will be accessible via the Investor Relations section of the Company’s Web site at www.supergen.com. A webcast replay of the live conference call will be available shortly following the event. Alternatively, you may access a replay of the conference call by dialing 1-888-286-8010 (domestic) and 1-617-801-6888 (international); replay passcode number is 40244536. The webcast replay and conference call replay will be available for 30 days.
About SuperGen
SuperGen is a pharmaceutical company dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit http://www.supergen.com.
SuperGen, Inc.
Timothy L. Enns, 925-560-2810
Senior Vice President, Corporate Communications & Business Development
tenns@supergen.com
Susanna Chau, 925-560-2845
Manager, Investor Relations
schau@supergen.com
Copyright © 2009 Business Wire. All rights reserved. All the news releases provided by Business Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials by posting, archiving in a public web site or database, or redistribution in a computer network is strictly forbidden.